Avenue Therapeutics Inc (ATXI)
3.815
+0.18
(+5.10%)
USD |
NASDAQ |
May 17, 16:00
3.88
+0.06
(+1.70%)
After-Hours: 20:00
Avenue Therapeutics Cash from Operations (Quarterly): -3.12M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.12M |
| December 31, 2023 | -2.324M |
| September 30, 2023 | -0.889M |
| June 30, 2023 | -4.665M |
| March 31, 2023 | -1.573M |
| December 31, 2022 | -4.169M |
| September 30, 2022 | -0.554M |
| June 30, 2022 | -0.943M |
| March 31, 2022 | -1.93M |
| December 31, 2021 | -1.203M |
| September 30, 2021 | -0.536M |
| June 30, 2021 | -0.704M |
| March 31, 2021 | -1.307M |
| December 31, 2020 | -1.193M |
| September 30, 2020 | -0.932M |
| June 30, 2020 | -1.317M |
| March 31, 2020 | -1.171M |
| Date | Value |
|---|---|
| December 31, 2019 | -4.996M |
| September 30, 2019 | -1.714M |
| June 30, 2019 | -13.98M |
| March 31, 2019 | -5.568M |
| December 31, 2018 | -1.238M |
| September 30, 2018 | -4.136M |
| June 30, 2018 | -6.023M |
| March 31, 2018 | -6.819M |
| December 31, 2017 | -4.268M |
| September 30, 2017 | -1.879M |
| June 30, 2017 | -0.621M |
| March 31, 2017 | -0.034M |
| December 31, 2016 | -0.073M |
| September 30, 2016 | -0.443M |
| June 30, 2016 | -0.239M |
| March 31, 2016 | -0.877M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.98M
Minimum
Jun 2019
-0.536M
Maximum
Sep 2021
-2.461M
Average
-1.312M
Median
Cash from Operations (Quarterly) Benchmarks
| Fortress Biotech Inc | -25.39M |
| SINTX Technologies Inc | -2.733M |
| Deciphera Pharmaceuticals Inc | -54.58M |
| Flora Growth Corp | -1.131M |
| NovaBay Pharmaceuticals Inc | -1.572M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 4.531M |
| Free Cash Flow | -11.00M |
| Free Cash Flow Per Share (Quarterly) | -416.39 |
| Free Cash Flow Yield | -2.10K% |